|
1
|
Lau W, Leung K, Leung TW, Liew CT, Chan
MS, Yu SC and Li AK: A logical approach to hepatocellular carcinoma
presenting with jaundice. Ann Surg. 225:281–285. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Uchima-Koecklin H, Balderramo D and
Cárdenas A: Bile duct hepatocellular carcinoma thrombi.
Gastroenterol Hepatol. 35:326–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ikenaga N, Chijiiwa K, Otani K, Ohuchida
J, Uchiyama S and Kondo K: Clinicopathologic characteristics of
hepatocellular carcinoma with bile duct invasion. J Gastrointest
Surg. 13:492–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu XG, Mao W, Hong SY, Kim BW, Xu WG and
Wang HJ: Surgical treatment for hepatocellular carcinoma with bile
duct invasion. Ann Surg Treat Res. 90:139–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oba A, Takahashi S, Kato Y, Gotohda N,
Kinoshita T, Shibasaki H, Ikeda M and Konishi M: Usefulness of
resection for hepatocellular carcinoma with macroscopic bile duct
tumor thrombus. Anticancer Res. 34:4367–4372. 2014.PubMed/NCBI
|
|
6
|
Xiangji L, Weifeng T, Bin Y, Chen L,
Xiaoqing J, Baihe Z, Feng S and Mengchao W: Surgery of
hepatocellular carcinoma complicated with cancer thrombi in bile
duct: Efficacy for criteria for different therapy modalities.
Langenbecks Arch Surg. 394:1033–1039. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu XH, Xu LB, Liu C, Zhang R and Wang J:
Clinicopathological characteristics of 20 cases of hepatocellular
carcinoma with bile duct tumor thrombi. Dig Dis Sci. 56:252–259.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeh CN, Jan YY, Lee WC and Chen MF:
Hepatic resection for hepatocellular carcinoma with obstructive
jaundice due to biliary tumor thrombi. World J Surg. 28:471–475.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ha TY, Hwang S, Moon DB, Ahn CS, Kim KH,
Song GW, Jung DH, Park GC, Park HW, Park YH, et al: Long-term
survival analysis of liver transplantation for hepatocellular
carcinoma with bile duct tumor thrombus. Transplant Proc.
46:774–777. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang YD, Xue HZ, Jiang QF, Shen Q, Wang
LC, Zhang X, Lu B, Yu M and Li K: Surgical operation and
re-operation for hepatocellular carcinoma with bile duct
thrombosis. Chin Med J (Engl). 123:2163–2170. 2010.PubMed/NCBI
|
|
11
|
Shiomi M, Kamiya J, Nagino M, Uesaka K,
Sano T, Hayakawa N, Kanai M, Yamamoto H and Nimura Y:
Hepatocellular carcinoma with biliary tumor thrombi: Aggressive
operative approach after appropriate preoperative management.
Surgery. 129:692–698. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin LX, Ma ZC, Wu ZQ, Fan J, Zhou XD, Sun
HC, Ye QH, Wang L and Tang ZY: Diagnosis and surgical treatments of
hepatocellular carcinoma with tumor thrombosis in bile duct:
Experience of 34 patients. World J Gastroenterol. 10:1397–1401.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng SY, Wang JW, Liu YB, Cai XJ, Deng GL,
Xu B and Li HJ: Surgical intervention for obstructive jaundice due
to biliary tumor thrombus in hepatocellular carcinoma. World J
Surg. 28:43–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang XW, Yuan JM, Chen JY, Yang J, Gao QG,
Yan XZ, Zhang BH, Feng S and Wu MC: The prognostic importance of
jaundice in surgical resection with curative intent for gallbladder
cancer. BMC Cancer. 14:6522014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
International Union Against Cancer: TNM
classification of malignant tumors. 7th edition. Wiley; New York:
2009
|
|
16
|
Charrez B, Qiao L and Hebbard L:
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The
state of play. World J Gastroenterol. 22:2494–2502. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Batsis JA, Halfdanarson TR and Pitot H:
Extra-hepatic hepatocellular carcinoma presenting as obstructive
jaundice. Dig Liver Dis. 38:768–771. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kojiro M, Kawabata K, Kawano Y, Shirai F,
Takemoto N and Nakashima T: Hepatocellular carcinoma presenting as
intrabile duct tumor growth: A clinicopathologic study of 24 cases.
Cancer. 49:2144–2147. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
European Association for the study of the
Liver, European Organisation for Research and Treatment of Cancer.
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM,
Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, et al: Survival
outcomes of hepatic resection compared with transarterial
chemoembolization or sorafenib for hepatocellular carcinoma with
portal vein tumor thrombosis. Clin Mol Hepatol. 22:160–167. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Minagawa M and Makuuchi M: Treatment of
hepatocellular carcinoma accompanied by portal vein tumor thrombus.
World J Gastroenterol. 12:7561–7567. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan WF, Qiu ZQ, Yu Y, Ran RZ, Yi B, Lau
WY, Liu C, Qiu YH, Feng FL, Wang JH, et al: Sorafenb extends the
survival time of patients with multiple recurrences of
hepatocellular carcinoma after liver transplantation. Acta
Pharmacol Sin. 31:1643–1648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pitt HA, Gomes AS, Lois JF, Mann LL,
Deutsch LS and Longmire WP Jr: Does preoperative percutaneous
biliary drainage reduce operative risk or increase hospital cost?
Ann Surg. 201:545–553. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto S, Hasegawa K, Inoue Y, Shindoh
J, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and Kokudo N: Bile
duct preserving surgery for hepatocellular carcinoma with bile duct
tumor thrombus. Ann Surg. 261:e123–e125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sewnath ME, Karsten TM, Prins MH, Rauws
EJ, Obertop H and Gouma DJ: A meta-analysis on the efficacy of
preoperative biliary drainage for the tumors causing obstructive
jaundice. Ann Surg. 236:17–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Agarwal AK, Mandal S, Singh S, Bhojwani R,
Sakhuja P and Uppal R: Biliary obstruction in gall bladder cancer
is not sine qua non of inoperability. Ann Surg Oncol. 14:2831–2837.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi J, Ryu JK, Lee SH, Ahn DW, Hwang JH,
Kim YT, Yoon YB and Han JK: Biliary drainage for obstructive
jaundice caused by unresectable hepatocellular carcinoma: The
endoscopic versus percutaneous approach. Hepatobiliary Pancreat Dis
Int. 11:636–642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cho HC, Lee JK, Lee KH, Lee KT, Paik S,
Choo SW, Do YS and Choo IW: Are endoscopic or percutaneous biliary
drainage effective for obstructive jaundice caused by
hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 23:224–231.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noda T, Nagano H, Tomimaru Y, Murakami M,
Wada H, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Tanemura M,
et al: Prognosis of hepatocellular carcinoma with biliary tumor
thrombi after liver surgery. Surgery. 149:371–377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen C, Chen PJ, Yang PM, Huang GT, Lai
MY, Tsang YM and Chen DS: Clinical and microbiological features of
liver abscess after transarterial embolization for hepatocellular
carcinoma. Am J Gastroenterol. 92:2257–2259. 1997.PubMed/NCBI
|
|
32
|
de Baère T, Risse O, Kuoch V, Dromain C,
Sengel C, Smayra T, El Din Gamal M, Letoublon C and Elias D:
Adverse events during radiofrequency treatment of 582 hapatic
tumors. AJR Am J Roentgenol. 181:695–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
A new prognostic system for hepatocellular
carcinoma: A retrospective study of 435 patients: The Cancer of the
Liver Italian Program (CLIP) investigators. Hepatology. 28:751–755.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung H, Kudo M, Takahashi S, Hagiwara S,
Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T and Matsunaga
T: Comparison of three current staging systems for hepatocellular
carcinoma: Japan integrated staging score, new Barcelona Clinic
Liver Cancer staging classification and Tokyo score. J
Gastroenterol Hepatol. 23:445–452. 2008. View Article : Google Scholar : PubMed/NCBI
|
